Published in Bone Marrow Transplant on January 12, 2009
Haploidentical vs cord blood transplantation for adults with acute myelogenous leukemia. World J Stem Cells (2014) 0.86
Validation of the EBMT Risk Score for South Brazilian Patients Submitted to Allogeneic Hematopoietic Stem Cell Transplantation. Bone Marrow Res (2013) 0.79
Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci (2000) 5.53
Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med (1994) 5.28
Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG (2006) 4.20
Spectrum bias in the evaluation of diagnostic tests: lessons from the rapid dipstick test for urinary tract infection. Ann Intern Med (1992) 3.64
Interprofessional education: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2008) 3.22
Intracellular cytokine profile of cord and adult blood lymphocytes. Blood (1998) 2.90
Experimental investigation of geologically produced antineutrinos with KamLAND. Nature (2005) 2.75
HTLV-I screening in Britain. BMJ (1995) 2.25
Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann Neurol (1989) 2.08
An unfortunate case of allergy to latex. Lancet (2000) 2.04
Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant (2001) 2.00
A laboratory comparison of T cell depletion by CD34+ cell immunoaffinity selection and in vitro Campath-1M treatment: clinical implications for bone marrow transplantation and donor leukocyte therapy. Bone Marrow Transplant (1997) 1.96
Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance. Trans R Soc Trop Med Hyg (1994) 1.96
Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia. Leukemia (2006) 1.95
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood (2000) 1.93
Cis-acting sequences regulating expression of the human alpha-globin cluster lie within constitutively open chromatin. Cell (1992) 1.92
Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro. Leukemia (2004) 1.84
Vocal cord dysfunction and wheezing. Thorax (1991) 1.82
Treatment of common bile duct injuries during laparoscopic cholecystectomy: endoscopic and surgical management. World J Surg (2001) 1.81
KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia (2009) 1.80
Microsaccades and the velocity-amplitude relationship for saccadic eye movements. Science (1965) 1.80
Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer. J Clin Oncol (1995) 1.80
Unusual HLA-B alleles in two tribes of Brazilian Indians. Nature (1992) 1.79
Alloreactive cloned T cell lines. VI. Multiple lymphokine activities secreted by helper and cytolytic cloned T lymphocytes. J Immunol (1982) 1.78
Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant (2007) 1.72
Separate ontogeny of two macrophage-like accessory cell populations in the human fetus. J Immunol (1986) 1.71
Leukoencephalopathy and raised brain lactate from heroin vapor inhalation ("chasing the dragon") Neurology (1999) 1.70
Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry (2000) 1.69
Healing of broken human chromosomes by the addition of telomeric repeats. Am J Hum Genet (1994) 1.69
Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood (1991) 1.69
Mutation update for the CSB/ERCC6 and CSA/ERCC8 genes involved in Cockayne syndrome. Hum Mutat (2010) 1.67
Evaluating organizational design to assure technology transfer: the case of the Community Clinical Oncology Program. J Natl Cancer Inst (1989) 1.65
Repression of transcriptional activity at a distance by the evolutionarily conserved KRAB domain present in a subfamily of zinc finger proteins. Nucleic Acids Res (1994) 1.60
The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis. Aliment Pharmacol Ther (2010) 1.60
Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut (2002) 1.60
An overview of three new disorders associated with genetic instability: LIG4 syndrome, RS-SCID and ATR-Seckel syndrome. DNA Repair (Amst) (2004) 1.60
Feasibility testing of an automated image-capture method to aid dietary recall. Eur J Clin Nutr (2011) 1.59
Measures to prevent TRALI. Vox Sang (2007) 1.58
p53 in chronic myelogenous leukemia in acute phase. Proc Natl Acad Sci U S A (1991) 1.56
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplant (2004) 1.55
Use of minisatellite DNA probes for recognition and characterization of relapse after allogeneic bone marrow transplantation. Br J Haematol (1988) 1.54
Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and improved overall survival. Bone Marrow Transplant (2007) 1.53
Nijmegen breakage syndrome diagnosed as Fanconi anaemia. Pediatr Blood Cancer (2005) 1.50
CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant (1997) 1.48
Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. Br J Haematol (1997) 1.48
Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol (2008) 1.47
Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev (2005) 1.47
New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia. Haematologica (1997) 1.47
Measurement of neutrino oscillation with KamLAND: evidence of spectral distortion. Phys Rev Lett (2005) 1.46
The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. Blood (2000) 1.46
Fatal donor-derived Epstein-Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated bone marrow transplant for myelodysplastic syndrome. Bone Marrow Transplant (2002) 1.46
The role of computerized tomography in the evaluation of complications after laparoscopic urological surgery. J Urol (1997) 1.43
Intensive treatment of renal failure in patients with myeloma. Clin Lab Haematol (1994) 1.43
Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) Blood (1995) 1.43
Arsenic and Ayurveda. Leuk Lymphoma (1993) 1.43
Guidelines for the investigation and management of mantle cell lymphoma. Br J Haematol (2012) 1.43
Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant (2000) 1.42
Cord blood banking. Vox Sang (2008) 1.41
Antifungal prophylaxis in haematology patients: the role of voriconazole. Clin Microbiol Infect (2012) 1.40
Economic evaluation of peripheral blood stem cell transplantation for lymphoma. Lancet (1992) 1.40
Imaging case of the month. Distal small bowel obstruction caused by lymphoma. Md Med J (1996) 1.39
Are changes in admission practices for elective surgery posing a transfusion threat to patients? Transfus Med (2002) 1.39
Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood (2001) 1.38
Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis. Leuk Res (2011) 1.38
Significance of Epstein-Barr virus status and post-transplant lymphoproliferative disease in pediatric thoracic transplantation. Pediatr Transplant (1999) 1.38
Measurement of the nucleon strange-antistrange asymmetry at next-to-leading order in QCD from NuTeV Dimuon data. Phys Rev Lett (2007) 1.38
Intracranial imaging. Postgrad Med J (1996) 1.37
Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplant (2003) 1.37
Protecting privacy to improve health care. Health Aff (Millwood) (1999) 1.36
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres. Br J Haematol (2001) 1.36
Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction. Br J Haematol (2000) 1.35
Colon cancer stem cells. Gut (2008) 1.35
Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report. Bone Marrow Transplant (2003) 1.34
The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis. Bone Marrow Transplant (2008) 1.32
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (1998) 1.30
Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. Leukemia (2009) 1.29
Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome. Bone Marrow Transplant (2006) 1.28
Imaging bowel obstruction: a comparison between fast magnetic resonance imaging and helical computed tomography. Clin Radiol (2002) 1.28
Allogeneic hematopoietic SCT for patients with autoimmune diseases. Bone Marrow Transplant (2009) 1.28
The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders. Proc Natl Acad Sci U S A (2000) 1.27
A dose-response analysis of methoxychlor-induced alterations of reproductive development and function in the rat. Fundam Appl Toxicol (1989) 1.26
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia. Bone Marrow Transplant (1998) 1.25
Inconsistency and institutional review boards. JAMA (1982) 1.24
Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet (1993) 1.24
5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox Sang (2008) 1.23
Phospholipid metabolism by phagocytic cells. VI. Observations on the fate of phospholipids of granulocytes and ingested Escherichia coli during phagocytosis. Biochim Biophys Acta (1972) 1.22
Cerebral embolism after mechanical thrombolysis of a clotted hemodialysis access. Am J Kidney Dis (1999) 1.22
Advances in therapeutic endoscopic treatment of common bile duct stones. World J Surg (1998) 1.22